Tuning NF-κB activity: A touch of COMMD proteins

被引:96
|
作者
Bartuzi, Paulina [1 ]
Hofker, Marten H. [1 ]
van de Sluis, Bart [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2013年 / 1832卷 / 12期
关键词
Inflammation; NF-kappa B; COMMD family; Scaffold; Termination; COPPER TOXICOSIS; GENE-EXPRESSION; ACTIVATION; MURR1; PHOSPHORYLATION; P65; CYLINDROMATOSIS; CYLD; UBIQUITINATION; IDENTIFICATION;
D O I
10.1016/j.bbadis.2013.09.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
NF-kappa B is an important regulator of immunity and inflammation, and its activation pathway has been studied extensively. The mechanisms that downregulate the activity of NF-kappa B have also received a lot of attention, particularly since its activity needs to be terminated to prevent chronic inflammation and subsequent tissue damage. The COMMD family has been identified as a new group of proteins involved in NF-kappa B termination. All ten COMMD members share the structurally conserved carboxy-terminal motif, the COMM domain, and are ubiquitously expressed. They seem to play distinct and non-redundant roles in various physiological processes, including NF-kappa B signaling. In this review, we describe the mechanisms and proteins involved in the termination of canonical NF-kappa B signaling, with a specific focus on the role of the COMMD family in the down-modulation of NF-kappa B. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:2315 / 2321
页数:7
相关论文
共 50 条
  • [11] NF-κB Signaling in the Aging Process
    Salminen, Antero
    Kaarniranta, Kai
    JOURNAL OF CLINICAL IMMUNOLOGY, 2009, 29 (04) : 397 - 405
  • [12] NF-κB regulation: the nuclear response
    Mankan, Arun K.
    Lawless, Matthew W.
    Gray, Steven G.
    Kelleher, Dermot
    McManus, Ross
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (04) : 631 - 643
  • [13] Role of NF-κB in thyroid cancer
    Pacifico, Francesco
    Leonardi, Antonio
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 321 (01) : 29 - 35
  • [14] In vitro benchmarking of NF-κB inhibitors
    Harrold, Alexandria P.
    Cleary, Megan M.
    Bharathy, Narendra
    Lathara, Melvin
    Berlow, Noah E.
    Foreman, Nicholas K.
    Donson, Andrew M.
    Amani, Vladimir
    Zuercher, William J.
    Keller, Charles
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 873
  • [15] Nuclear-Cytosolic Transport of COMMD1 Regulates NF-κB and HIF-1 Activity
    Muller, Patricia A. J.
    van de Sluis, Bart
    Groot, Arjan J.
    Verbeek, Dineke
    Vonk, Willianne I. M.
    Maine, Gabriel N.
    Burstein, Ezra
    Wijmenga, Cisca
    Vooijs, Marc
    Reits, Eric
    Klomp, Leo W. J.
    TRAFFIC, 2009, 10 (05) : 514 - 527
  • [16] NF-κB signaling
    O'Dea, Ellen
    Hoffmann, Alexander
    WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE, 2009, 1 (01) : 107 - 115
  • [17] Monoubiquitination of nuclear RelA negatively regulates NF-κB activity independent of proteasomal degradation
    Hochrainer, Karin
    Racchumi, Gianfranco
    Zhang, Sheng
    Iadecola, Costantino
    Anrather, Josef
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2012, 69 (12) : 2057 - 2073
  • [18] SUMOylation Attenuates the Transcriptional Activity of the NF-κB Subunit RelB
    Leidner, Julia
    Voogdt, Cornelia
    Niedenthal, Rainer
    Moeller, Peter
    Marienfeld, Uta
    Marienfeld, Ralf B.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2014, 115 (08) : 1430 - 1440
  • [19] The deubiquitinase activity of A20 is dispensable for NF-κB signaling
    De, Arnab
    Dainichi, Teruki
    Rathinam, Chozha Vendan
    Ghosh, Sankar
    EMBO REPORTS, 2014, 15 (07) : 775 - 783
  • [20] Clusterin Facilitates COMMD1 and I-κB Degradation to Enhance NF-κB Activity in Prostate Cancer Cells
    Zoubeidi, Amina
    Ettinger, Susan
    Beraldi, Eliana
    Hadaschik, Boris
    Zardan, Anousheh
    Klomp, Leo W. J.
    Nelson, Colleen C.
    Rennie, Paul S.
    Gleave, Martin E.
    MOLECULAR CANCER RESEARCH, 2010, 8 (01) : 119 - 130